Yahoo
NasdaqGM - Nasdaq Real Time Price USD

Structure Therapeutics Inc. (GPCR)

21.87 -0.07 (-0.32%)
At close: October 30 at 4:00:01 PM EDT
22.01 +0.14 (+0.64%)
After hours: October 30 at 6:54:36 PM EDT
Trade GPCR on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
0
0
Operating Expense
268,056
186,809
158,228
102,775
52,561
Operating Income
-268,056
-186,809
-158,228
-102,775
-52,561
Net Non Operating Interest Income Expense
43,674
35,873
36,012
13,391
1,257
Other Income Expense
--
10,249
--
--
--
Pretax Income
-214,133
-140,687
-122,216
-89,384
-51,304
Tax Provision
702
515
310
236
17
Net Income Common Stockholders
-214,835
-141,202
-122,526
-89,620
-52,836
Diluted NI Available to Com Stockholders
-214,835
-141,202
-122,526
-89,620
-52,836
Basic EPS
-3.03
-1.99
-2.14
-2.43
-1.38
Diluted EPS
-3.03
-1.99
-2.14
-2.43
-1.38
Basic Average Shares
66,747.33
70,837.67
57,286.67
36,732.67
38,243.18
Diluted Average Shares
66,747.33
70,837.67
57,286.67
36,732.67
38,243.18
Total Operating Income as Reported
-257,807
-176,560
-158,228
-102,775
-52,561
Total Expenses
268,056
186,809
158,228
102,775
52,561
Net Income from Continuing & Discontinued Operation
-214,835
-141,202
-122,526
-89,620
-51,321
Normalized Income
-220,984.40
-149,298.71
-122,526
-89,620
-51,321
Net Interest Income
43,674
35,873
36,012
13,391
1,257
EBIT
-268,056
-186,809
-158,228
-102,775
-52,561
EBITDA
-266,161
-185,476
-157,236
-102,480
-52,284
Reconciled Depreciation
1,895
1,333
992
295
277
Net Income from Continuing Operation Net Minority Interest
-214,835
-141,202
-122,526
-89,620
-51,321
Total Unusual Items Excluding Goodwill
10,249
10,249
0
0
--
Total Unusual Items
10,249
10,249
0
0
--
Normalized EBITDA
-276,410
-195,725
-157,236
-102,480
-52,284
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
4,099.60
2,152.29
0
0
0
12/31/2022 - 2/3/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: